Advanced search
Publication Cover
Current Medical Research and Opinion Volume 28, 2012 - Issue 2
Submit an article Journal homepage
699
Views
14
CrossRef citations to date
0
Altmetric
Respiratory: Original Article

Efficacy and safety of budesonide/formoterol via a dry powder inhaler in Chinese patients with chronic obstructive pulmonary disease

Nanshan ZhongState Key Lab of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical College Guangzhou, China
,
Jinping ZhengState Key Lab of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical College Guangzhou, ChinaCorrespondence[email protected]
,
Fuqiang WenWest China Hospital, Sichuan University Chengdu, China
,
Lan YangFirst Affiliated Hospital of Medical College of Xi’an Jiaotong University Xi’an, China
,
Ping ChenGeneral Hospital of Shenyang Military Command Shenyang, China
,
Qingyu XiuShanghai Changzheng Hospital Shanghai, China
,
Wanzhen YaoPeking University Third Hospital Beijing, China
,
Tieying SunBeijing Hospital Beijing, China
,
Ziwen ZhaoGuang Zhou First Municipal People’s Hospital Guangzhou, China
,
Huahao ShenSecond Affiliated Hospital Zhejiang University College of Medicine Hangzhou, China
,
Yi ShiNanjing General Hospital of Nanjing Military Command Nanjing, China
,
Jiangtao LinChina–Japan Friendship Hospital Beijing, China
&
Qiang LiShanghai Changhai Hospital Shanghai, China
 show all
Pages 257-265 | Accepted 25 Oct 2011, Published online: 20 Jan 2012

References

  • Pulmonary Disease Group in Respiratory Disease Branch of China Medical Association. Guideline for Chronic Obstructive Pulmonary Disease diagnosis and treatment (Chinese, revised 2007). Chin J Tuberc Respir Dis 2007;30:8-17
  • Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007;176:753-60
  • National Institutes of Health. Global Initiative for Chronic Obstructive Lung Disease guidelines (GOLD) updated 2008. Available at: http://www.goldcopd.com
  • Barnes PJ. Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids. Eur Respir J 2002;19:182-91
  • Szafranski W, Cukier A, Ramirez A, et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 2003;21:74-81
  • Calverley PM, Boonsawat W, Cseke Z, et al. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J 2003;22:912-19
  • Zheng JP, Yang L, Wu YM, et al. The efficacy and safety of combination salmeterol (50 μg)/fluticasone propionate (500 μg) inhalation twice daily via accuhaler in Chinese patients with COPD. Chest 2007;132:1756-63
  • Calverley P, Pauwels R, Vestbo J. for the TRISTAN study group. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 2003;361:449-56
  • Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests. European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Resp J 1993;6(Suppl 16):5-40
  • Jones PW, Quirk FH, Baveystock CM. The St George’s Respiratory Questionnaire. Respir Med 1991;85(Suppl B):25-31
  • Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7
  • Jones, PW. St George’s Respiratory Questionnaire: development, interpretation and use. Eur Respir Rev 2002;12:63-4
  • Balanag VM, Yunus F, Yang PC, et al. Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. Pulm Pharmacol Ther 2006;19:139-47
  • Zheng JP, Kang J, Huang SG, et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomized placebo controlled study. Lancet 2008;371:2013-18
  • Partridge MR, Schuermann W, Beckman O, et al. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. Ther Adv Respir Dis 2009;3:147-57

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.